Type 2 diabetes continues to be a serious and highly prevalent public health problem
worldwide. In 2019, the highest prevalence of diabetes in the world at 12.2%, with its …

Background. CVD is a principal cause of mortality and disability globally. Objective. To
analyse the epidemiological data on CHD, strokes, and the associated risk factors among …

There is concern about an emerging diabetes epidemic in Turkey. We aimed to determine
the prevalence of diagnosed and undiagnosed diabetes, prediabetes and their 12-year …

摘要背景: 在非洲以及全世界范围内糖尿病都是一个主要的健康问题. 预计非洲的糖尿病患病率
将会以极高的速率在不断升高. 据估计目前有2 千万非洲人患糖尿病, 这对于目前以及将来的 …

Aims We estimated the number of live births worldwide and by IDF Region who developed
hyperglycaemia in pregnancy in 2013, including total diabetes in pregnancy (known and …

Background The prevalence of gestational diabetes (GDM) is increasing all over the world.
Hence, the impact of GDM on maternal and infant health is an important topic of research …

The anti-diabetic and oral hypoglycaemic agent metformin, first used clinically in 1958, is
today the first choice or 'gold standard'drug for the treatment of type 2 diabetes and …

Background Patients' non-adherence to diabetes medication is associated with poor
glycemic control and suboptimal benefits from their prescribed medication, which can lead to …

The global epidemic of diabetes has not spared the Arabic‐speaking countries, which have
some of the highest prevalence of type II diabetes. This is particularly true of the Arab Gulf, a …

Diabetes is a global health problem, and the number of diabetic patients is in continuous
rise. Conventional antidiabetic therapies are associated with high costs and limited …